1. Santos-Sancho JM, Jimenez-Trujillo I, Hernandez-Barrera V, Lopez-de Andres A, et al. (2012). Influenza vaccination coverage and uptake predictors among Spanish adults suffering COPD. Human Vaccines and Immunotherapeutics 8(7 ):938-945.
2. Gutierrez L, Roskell N, Castellsague J, Beard S, et al. (2012). Clinical burden and incremental cost of fractures in postmenopausal women in the United Kingdom. Bone 51(3 ):324-331.
3. Iizuka Y, Shinozaki T, Kobayashi T, Tsutsumi S, et al. (2012). Characteristics of neck and shoulder pain (called katakori in Japanese) among members of the nursing staff. Journal of Orthopaedic Science 17(1 ):46-50.
4. Ochoa S, Salvador-Carulla L, Villalta-Gil V, Gibert K, et al. (2012). Use of functioning-disability and dependency for case-mix and subtyping of schizophrenia. European Journal of Psychiatry 26(1 ):5-20.
5. Abramczyk A. (2012). Results of specialized ambulatory diabetes care among diabetes patients at the level of primary health care - In the light of nationwide research. Advances in Clinical and Experimental Medicine 21(1 ):63-68.
6. Chapman S, MacKenzie R. (2012). Can it be ethical to apply limited resources in low-income countries to ineffective, low-reach smoking cessation strategies? A reply to Bitton and Eyal. Public Health Ethics 5(1 ):29-37.
7. Maalej S, Yaacoub Z, Fakhfekh R, Yaalaoui S, et al. (2012). Association of obesity with asthma severity, control and quality of life. Tanaffos 11(1 ):38-43.
8. Zejda JE, Brozek GM, Farnik M, Smolka I. (2012). Social and family-related correlates of medical care utilization by asthmatic children in Upper Silesia, Poland. Annals of Agricultural and Environmental Medicine 19(1 ):141-145.
9. Korber S, Hiller W. (2012). [Medically unexplained symptoms and somatoform disorders in primary care]. Journal fur Neurologie, Neurochirurgie und Psychiatrie 13(1 ):21-28.
10. Ozgocmen S, Akgul O, Akinci A, Ataman S, et al. (2012). Agreement of Turkish physiatrists with the assessment in spondyloarthritis international society and the European league against rheumatism recommendations for the management of ankylosing spondylitis and rheumatoid arthritis. Open Rheumatology Journal 6(1 ):1-5.
11. Sandberg M, Kristensson J, Midlov P, Fagerstrom C, et al. (2012). Prevalence and predictors of healthcare utilization among older people (60+): Focusing on ADL dependency and risk of depression. Archives of Gerontology and Geriatrics 54(3 ):e349-e363.
12. Carnes D, Homer KE, Miles CL, Pincus T, et al. (2012). Effective delivery styles and content for self-management interventions for chronic musculoskeletal pain: A systematic literature review. Clinical Journal of Pain 28(4 ):344-354.
13. Harms L, Sieb J-P, Williams AE, Graham R, et al. (2012). Long-term disease history, clinical symptoms, health status, and healthcare utilization in patients suffering from Lambert Eaton myasthenic syndrome: Results of a patient interview survey in Germany. Journal of Medical Economics 15(3 ):521-530.
14. Lee W-C, Chen T-J. (2012). Quantifying morbidity burdens and medical utilization of children with intellectual disabilities in Taiwan: A nationwide study using the ACG case-mix adjustment system. Research in Developmental Disabilities 33(4 ):1270-1278.
15. Ackerman IN, Buchbinder R, Osborne RH. (2012). Challenges in evaluating an Arthritis Self-Management Program for people with hip and knee osteoarthritis in real-world clinical settings. Journal of Rheumatology 39(5 ):1047-1055.
16. Marzolini S, Oh PI, Alter D, Stewart DE, et al. (2012). Musculoskeletal comorbidities in cardiac patients: Prevalence, predictors, and health services utilization. Archives of Physical Medicine and Rehabilitation 93(5 ):856-862.
17. Hattori N, Hirayama T, Katayama Y. (2012). Medical care for chronic-phase stroke in Japan. Neurologia Medico-Chirurgica 52(4 ):175-180.
18. Fischer JA, Clavarino AM, Najman JM. (2012). Drug, sex and age differentials in the use of Australian publicly funded treatment services. Substance Abuse: Research and Treatment 6(1 ):13-21.
19. Pit'ha J, Bednarik J, Zapletalova O, Schutzner J, et al. (2012). [Guideline for the diagnosis and therapy of myasthenia gravis]. Ceska a Slovenska Neurologie a Neurochirurgie 75(2 ):244-252.
20. Baandrup L, Sorensen J, Lublin H, Nordentoft M, et al. (2012). Association of antipsychotic polypharmacy with health service cost: A register-based cost analysis. European Journal of Health Economics 13(3 ):355-363.
21. Moss-Morris R, McCrone P, Yardley L, van Kessel K, et al. (2012). A pilot randomised controlled trial of an Internet-based cognitive behavioural therapy self-management programme (MS Invigor8) for multiple sclerosis fatigue. Behaviour Research and Therapy 50(6 ):415-421.
22. Rive B, Aarsland D, Grishchenko M, Cochran J, et al. (2012). Cost-effectiveness of memantine in moderate and severe Alzheimer''s disease in Norway. International Journal of Geriatric Psychiatry 27(6 ):573-582.
23. Chang H-C, Tang C-H, Huang S-T, McCrone P, et al. (2012). A cost-consequence analysis of long-acting injectable risperidone in schizophrenia: A one-year mirror-image study with national claim-based database in Taiwan. Journal of Psychiatric Research 46(6 ):751-756.